Luciani, Alessandro <br/><br/>
Targeting autophagy as a novel strategy for facilitating the therapeutic action of potentiators on ΔF508 cystic fibrosis transmembrane conductance regulator.  [electronic resource] 

 -  Autophagy  Nov 2012 
 - 1657-72 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1554-8635 
<br/><br/><label>Standard No.: </label>10.4161/auto.21483  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adaptor Proteins, Signal Transducing--metabolism<br/>Adolescent<br/>Animals<br/>Antioxidants--pharmacology<br/>Apoptosis Regulatory Proteins--metabolism<br/>Autophagy--drug effects<br/>Beclin-1<br/>Cell Membrane--drug effects<br/>Child<br/>Cystamine--pharmacology<br/>Cystic Fibrosis--drug therapy<br/>Cystic Fibrosis Transmembrane Conductance Regulator--metabolism<br/>Epithelial Cells--drug effects<br/>Epithelium--drug effects<br/>Female<br/>Genistein--pharmacology<br/>Heat-Shock Proteins--metabolism<br/>Humans<br/>Inflammation--pathology<br/>Lipopolysaccharides--pharmacology<br/>Lung--drug effects<br/>Male<br/>Membrane Proteins--metabolism<br/>Mice<br/>Molecular Targeted Therapy<br/>Nasal Mucosa--drug effects<br/>Nasal Polyps--pathology<br/>Organometallic Compounds--pharmacology<br/>Protein Glutamine gamma Glutamyltransferase 2<br/>Salicylates--pharmacology<br/>Sequestosome-1 Protein